Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: A population-based study

European Journal of Cancer

Volumn 43, Issue 3, 2007, Pages 565-575

  Cronin Fenton, D P ^a   Sharp, L ^a   Carsin, A E ^a   Comber, H ^a  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

Author keywords

Adenocarcinoma; Gastric cardia cancer; Oesophageal cancer; Surgery; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIA CARCINOMA; COMMUNITY CARE; ESOPHAGUS CANCER; FEMALE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; STOMACH CANCER; TUMOR LOCALIZATION;

ADULT; AGED; CARDIA; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; HUMANS; IRELAND; MIDDLE AGED; REGRESSION ANALYSIS; STOMACH NEOPLASMS;

EID: 33846658703     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.10.011     Document Type: Article

References (40)

1. Levi F., Lucchini F., Gonzalez J.R., Fernandez E., Negri E., and La Vecchia C. Monitoring falls in gastric cancer mortality in Europe. Ann Oncol 15 2 (2004) 338-345
2. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 10 (1998) 2049-2053
3. Blot W.J., and McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 26 5 Suppl. 15 (1999) 2-8
4. Verdecchia A., Corazziari I., Gatta G., Lisi D., Faivre J., Forman D., and EUROCARE Working Group. Explaining gastric cancer survival differences among European countries. Int J Cancer 109 5 (2004) 737-741
5. Wu P.C., and Posner M.C. The role of surgery in the management of oesophageal cancer. Lancet Oncol 4 8 (2003) 481-488
6. Faivre J., Forman D., Esteve J., Gatta G., and EUROCARE Working Group. Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer 34 14 Spec. No. (1998) 2167-2175
7. Verdecchia A., Corazziari I., Gatta G., et al. Explaining gastric cancer survival differences among European countries. Int J Cancer 109 5 (2004) 737-741
8. Lerut T., Nafteux P., Moons J., et al. Quality in the surgical treatment of cancer of the esophagus and gastroesophageal junction. Eur J Surg Oncol 31 6 (2005) 587-594
9. Macdonald J.S., Smalley S.R., Benedetti J., Hundahl S.A., Estes N.C., Stemmermann G.N., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. New Engl J Med 345 10 (2001) 725-730
10. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. New Engl J Med 335 7 (1996) 462-467
11. Koea J.B., Karpeh M.S., and Brennan M.F. Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients. Ann Surg Oncol 7 5 (2000) 346-351
12. Matley P.J., Dent D.M., Madden M.V., and Price S.K. Gastric carcinoma in young adults. Ann Surg 208 5 (1988) 593-596
13. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97 19 (2005) 1407-1427
14. Potosky A.L., Harlan L.C., Kaplan R.S., Johnson K.A., and Lynch C.F. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20 5 (2002) 1192-1202
15. van Spronsen D.J., Janssen-Heijnen M.L., Lemmens V.E., Peters W.G., and Coebergh J.W. Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer 41 7 (2005) 1051-1057
16. Cronin D.P., Harlan L.C., Clegg L.X., et al. Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin's lymphoma. Hematol Oncol 23 2 (2005) 73-81
17. Bouvier A.M., Binquet C., Gagnaire A., et al. Management and prognosis of esophageal cancers: has progress been made?. Eur J Cancer 42 2 (2006) 228-233
18. Cancer in Ireland, 1994 to 1998: incidence, mortality, treatment and survival. Report of the National Cancer Registry, Ireland. Cork; 2001.
19. In: Young Jr. J.L., Roffers S.D., Ries L.A.G., Fritz A.G., and Hurlbut A.A. (Eds). SEER summary staging manual - 2000: codes and coding instructions (2001), NIH, Bethesda (MD)
20. Koppert L.B., Janssen-Heijnen M.L., Louwman M.W., et al. Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study. Eur J Gastroenterol Hepatol 16 7 (2004) 681-688
21. Malthaner R, Collin S, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. In: The Cochrane Collaboration; 2006.
22. Sabharwal T., Morales J.P., Irani F.G., and Adam A. CIRSE: Cardiovascular and Interventional Radiological Society of Europe. Quality improvement guidelines for placement of esophageal stents. Cardiovasc Intervent Radiol 28 3 (2005) 284-288
23. Cronin-Fenton DP, Harlan LC, Clegg LX, Mooney MM. Patterns of care and survival in a population-based sample of patients diagnosed with gastric cancer in; 2006 [personal communication].
24. Adam D.J., Craig S.R., Sang C.T., Cameron E.W., and Walker W.S. Esophagectomy for carcinoma in the octogenarian. Ann Thorac Surg 61 1 (1996) 190-194
25. Tanisada K., Teshima T., Ikeda H., Abe M., Owen J.B., Hanks G.E., et al. A preliminary outcome analysis of the Patterns of Care Study in Japan for esophageal cancer patients with special reference to age: non surgery group. Int J Radiat Oncol Biol Phys 46 5 (2000) 1223-1233
26. Suntharalingam M., Moughan J., Coia L.R., et al. Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus. J Clin Oncol 23 10 (2005) 2325-2331
27. Bonavina L., Incarbone R., Saino G., et al. Clinical outcome and survival after esophagectomy for carcinoma in elderly patients. Dis Esophagus 16 2 (2003) 90-93
28. Sabel M.S., Smith J.L., Nava H.R., et al. Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol 9 2 (2002) 210-214
29. Gosney M.A. Clinical assessment of elderly people with cancer. Lancet Oncol 6 10 (2005) 790-797
30. Rouvelas I., Zeng W., Lindblad M., et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 6 11 (2005) 864-870
31. Trivers K.F., De Roos A.J., Gammon M.D., et al. Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol 3 3 (2005) 225-230
32. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., and Hennessy T.P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. New Engl J Med 335 7 (1996) 462-467
33. Potosky A.L., Harlan L.C., Kaplan R.S., et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20 5 (2002) 1192-1202
34. Kravdal O. The impact of marital status on cancer survival. Soc Sci Med 52 3 (2001) 357-368
35. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. New Engl J Med 345 10 (2001) 725-730
36. Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. In: The Cochrane Collaboration; 2006.
37. Arnott S, Duncan W, Ggnoux M, Girling DJ, Hansen HS, Launois B et al., Preoperative radiotherapy for esophageal carcinoma. In: The Cochrane Collaboration; 2006.
38. Rosenbaum P., and Rubin D.B. Reducing bias in observational studies using subclassification on the propensity score. JASA 79 (1984) 516-524
39. Polednak A.P. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer 105 1 (2003) 98-100
40. Allum W.H., Griffin S.M., Watson A., and Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut 50 Suppl. 5 (2002) v1-v23